Yu Zailin, Dai Yuehan
Peking University College of Life Sciences, Beijing, China.
Biotechnol J. 2006 Nov;1(11):1253-7. doi: 10.1002/biot.200600086.
The Chinese biotech industry is going through a period of fast growth, and with its huge population, China is predicted to be the biggest single-country market in the world. However, the Chinese biotech industry has to tackle the critical issue of innovation, which should be the driving force for China's development into an advanced and responsible country. Here, in this article, the authors review the history of the Chinese biotech industry, exemplified by the development of genetically engineered drugs during the last 20 years, and also point out its the future.
中国生物技术产业正经历快速发展时期，凭借其庞大的人口规模，中国预计将成为全球最大的单一国家市场。然而，中国生物技术产业必须应对创新这一关键问题，而创新应成为中国发展成为先进且负责任国家的驱动力。在此，本文作者回顾了中国生物技术产业的历史，以上述过去20年基因工程药物的发展为例，并指出了其未来发展方向。
